Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2017 18:00 ET | Source: Wolf Haldenstein Adler Freeman & Herz LLP

IMPORTANT SCYNEXIS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against SCYNEXIS, Inc. in the District of New Jersey

NEW YORK, March 17, 2017 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against SCYNEXIS, Inc. (“Scynexis” or the...
March 15, 2017 23:01 ET | Source: Faruqi & Faruqi LLP

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In SCYNEXIS, Inc. To Contact The Firm Before Lead Plaintiff Deadline

NEW YORK, March 15, 2017 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in SCYNEXIS, Inc. (“SCYNEXIS” or the “Company”) (NASDAQ:SCYX) of the...
March 14, 2017 16:55 ET | Source: Adverum Biotechnologies, Inc.

Adverum Biotechnologies, Inc. Appoints Patrick Machado, J.D. to Board of Directors

-- Mr. Machado to Chair Audit Committee -- MENLO PARK, Calif., March 14, 2017 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a leading gene therapy company advancing novel...
March 14, 2017 16:14 ET | Source: Brower Piven, A Professional Corporation

SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In SCYNEXIS, Inc. (SCYX) To Contact Brower Piven Before The Lead Plaintiff Deadline

STEVENSON, Md., March 14, 2017 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the...
March 14, 2017 10:00 ET | Source: The Law Offices of Vincent Wong

SCYX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving SCYNEXIS, Inc. and a Lead Plaintiff Deadline of May 8, 2017

NEW YORK, March 14, 2017 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors...
March 13, 2017 16:30 ET | Source: SCYNEXIS, Inc.

SCYNEXIS Reports Full Year 2016 Financial Results and Provides Company Update

JERSEY CITY, N.J., March 13, 2017 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ:SCYX), a drug development company committed to the development and commercialization of novel anti-infectives to address...
March 10, 2017 20:00 ET | Source: Gainey McKenna & Egleston

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. (SCYX)

NEW YORK, March 10, 2017 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against SCYNEXIS, Inc. (“Scynexis” or the “Company”) (NASDAQ:SCYX) in...
March 10, 2017 11:22 ET | Source: Levi & Korsinsky, LLP

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of SCYNEXIS, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 8, 2017 – SCYX

NEW YORK, March 10, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of...
March 08, 2017 14:29 ET | Source: Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against SCYNEXIS, Inc. and Certain Officers – SCYX

NEW YORK, March 08, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against SCYNEXIS, Inc. (“Scynexis” or the “Company”) (NASDAQ:SCYX) and certain of its...
March 07, 2017 09:05 ET | Source: SCYNEXIS, Inc.

SCYNEXIS, Inc. to Present at the 29th Annual ROTH Conference

JERSEY CITY, N.J., March 07, 2017 (GLOBE NEWSWIRE) -- Drug development company SCYNEXIS, Inc. (NASDAQ:SCYX) today announced that the Company will present at the 29th Annual ROTH Conference at the...